Publicaciones en colaboración con investigadores/as de Ghent University Hospital (29)

2024

  1. Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update

    Blood

2023

  1. Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial

    The Lancet Respiratory Medicine, Vol. 11, Núm. 10, pp. 894-904

2022

  1. Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 79, Núm. 20, pp. 1986-1997

  2. Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 study

    Gynecologic Oncology, Vol. 165, Núm. 1, pp. 40-48

  3. Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy

    Circulation. Arrhythmia and electrophysiology, Vol. 15, Núm. 5, pp. e010075

2021

  1. Global parental leave in surgical careers: differences according to gender, geographical regions and surgical career stages

    The British journal of surgery, Vol. 108, Núm. 11, pp. 1315-1322

  2. Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

    BJS Open

  3. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score

    British Journal of Surgery, Vol. 19, Núm. 4

  4. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

    Journal of Hepatology, Vol. 74, Núm. 5, pp. 1097-1108

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party

    Bone Marrow Transplantation, Vol. 55, Núm. 6, pp. 1050-1058

  3. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  4. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

    Journal of Hepatology, Vol. 73, Núm. 4, pp. 842-854

2019

  1. Validation of a Novel System for Co-Registration of Coronary Angiographic and Intravascular Ultrasound Imaging

    Cardiovascular Revascularization Medicine, Vol. 20, Núm. 9, pp. 775-781

2017

  1. Etestw versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: Results from PREMIUM, a European multicentre study

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 2, pp. 431-436

  2. Uso atual e aceitabilidade de novos testes diagnósticos para tuberculose ativa: Um inquérito mundial

    Jornal Brasileiro de Pneumologia, Vol. 43, Núm. 5, pp. 380-392

2015

  1. Determinants of downloads and citations for articles published in intensive care medicine

    Intensive Care Medicine Experimental

  2. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

  3. Outcome of manuscripts rejected from intensive care medicine: An in silico study

    Intensive Care Medicine Experimental

2014

  1. Doporuečené postupy European Renal Best Practice (ERBP) pro posuzování dárců a příjemců pro transplantaci ledviny a pro perioperační péči

    Aktuality v Nefrologii, Vol. 20, Núm. 2, pp. 78-85